Alkem CEO Gupta Resigns, Stays Until Mid-2026

Alkem Laboratories' Chief Executive Officer, Vikas Gupta, has formally submitted his resignation. He will continue to serve in his role until June 30, 2026, a period designated for ensuring a smooth and orderly transition of his duties. This decision comes as Gupta seeks to pursue new professional ventures that better align with his long-term personal and professional objectives. Gupta brings a wealth of experience, including a medical degree and deep knowledge of the Indian market, having previously held positions at Cipla, Glenmark, and Ranbaxy. The company's shares saw a decline of 5.17% on the NSE following the announcement. Alkem Laboratories, founded in 1973, is a prominent pharmaceutical company with a significant global footprint.

Gupta expressed that stepping down was not an easy decision but a necessary one for his future career path. He extended his gratitude to his colleagues for their collaboration during challenging periods and wished the company continued success. His previous experience at Cipla, where he led the India formulations business, highlights his expertise in the pharmaceutical sector. Reports suggest that Gupta has been approached by several organizations, including private equity firms, for leadership roles, indicating his strong standing in the industry. Alkem Labs, headquartered in Mumbai, operates in over 40 countries, with key markets in India and the US.